How Vaccines Are Made and Manufactured: Viral Vector Platform
Viral vector-based vaccines constitute a promising part of the biopharmaceutical pipeline, addressing many unmet indications. Some estimates show that half of the front runners of vaccine candidates for COVID-19 have used the viral vector platform. Moreover this is a complex platform with more than 40 vectors being used for both gene therapy and vaccines. Watch this video to learn how vaccines are manufactured using a viral-vector platform.
VIEW THE VIDEO! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online X
Subscribe to Bioprocess Online